Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Nan Ning, China Clinical Trials

A listing of Nan Ning, China clinical trials actively recruiting patients volunteers.

RESULTS

Found (2) clinical trials

Study of TQB2303 in Patients With CD20-Positive Diffuse Large B-cell Lymphoma (DLBCL)

The Purpose of This Study is to Compare the Efficacy, Safety, Immunogenicity and Pharmacokinetics between TQB2303 and Rituximab in Combination With CHOP in Previously Untreated Patients with Diffuse Large B-cell Lymphoma

Phase

0.0 miles

Learn More »

Albumin for Hepatocellular Carcinoma

The rate of liver cirrhosis is about 40% to 75% among patients with hepatocellular carcinoma (HCC). Therefore, many patients with HCC were with low serum albumin before and after (especially) hepatic resection. Serum albumin level has been routinely used in clinical practice as a surrogate marker to evaluate nutritional status ...

Phase

1.26 miles

Learn More »